Servier’s Strategic Presence at BIO 2025
News
Servier Pharmaceuticals Named a ‘Best Place to Work’ by Boston Business Journal for the Fifth Consecutive Year
Stefan Gross, Head of Biochemistry at Servier: Driving Innovation in Drug Discovery
Servier Ranked Among Top Companies Across Several Categories in 2024 PatientView Corporate Reputation of Pharma Survey
Servier to Acquire Exclusive Worldwide Rights of BioNova’s BN104, a potential best-in-class menin inhibitor
Servier Presentations at ASCO 2025 Reinforce Company Leadership in IDH-Mutated Cancers
Shining a Light on Chondrosarcoma: A Rare Disease with Urgent Needs
Servier’s Golden Ticket goes to Viska Bio for its innovative scientific approach in hard-to-treat cancers
For Tara Brown, National Blood Donor Month is the “Gift of Hope and Survival”